SAM PROVIDER TOOLKIT

Similar documents
SAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST QUESTIONS. Ver. #

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Chapter 12: Training in Pathology. DDSEP Chapter 13: Question 19

Barrett s Esophagus: Old Dog, New Tricks

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?

Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

The presence of intestinal-type goblet cells (ITGCs) in

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Oesophagus and Stomach update dysplasia and early cancer

Histopathology: gastritis and peptic ulceration

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

IBD. Crohn s. Outline. Ulcerative colitis versus Crohn s disease: is biopsy useful? UC vs. Crohn s? Is it easy? Biopsy settings 21/07/2017 IBD

Primary mucinous adenocarcinoma developing in an ileostomy stoma

Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions

5/2/2018. Low Grade Dysplasia of GI Tract. High Grade Dysplasia of GI Tract. Dysplasia in Gastrointestinal Tract: Practical Pearls and Issues

THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, by Am. Coll. of Gastroenterology ISSN /02/$22.00

Burning Issues in the Esophagus

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

3/30/2017. Disclosure of Relevant Financial Relationships. Case 5: Polypoid mass in ulcerative colitis. Case 5. TC Smyrk

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

Supplemental Digital Content 1. Endoscopic and histolological findings in INR and FR study subjects

General Structure of Digestive Tract

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Small Intestine, Large Intestine and anal cannel

Adenocarcinoma of the distal esophagus is a recognized

Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

Stage 4 gastric adenocarcinoma icd 10

DIGESTIVE TRACT ESOPHAGUS

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

하부위장관비종양성질환의 감별진단 주미인제의대일산백병원

Division of Anatomic Pathology & Molecular Oncology, University of Utah and ARUP Laboratories, Huntsman Cancer Institute, Salt Lake City, UT, USA

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you)

Supplementary Methods: Omalizumab Trial This double-blind, randomized, placebo-controlled trial was conducted at the University of Utah Hospital and

Esophageal submucosal mass icd 10

Patterns of Colonic Involvement at Initial Presentation in Ulcerative Colitis A Retrospective Study of 46 Newly Diagnosed Cases

Original Article. Atypical histological features of ulcerative colitis. Siddharth N Shah, 1 Anjali D Amarapurkar, 1 N Shrinivas, 2 Rathi PM 2 ABSTRACT

INTERNATIONAL COURSE ON THE PATHOLOGY OF THE DIGESTIVE SYSTEM VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY BUCHAREST 7-8 BUCHAREST 2014

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

TRICHURIASIS : LOCALIZED INFLAMMATORY RESPONSES IN THE COLON

THE USE OF SPECIAL STAINS IN THE DIAGNOSIS OF BARRETT ESOPHAGUS AND BARRETT DYSPLASIA: RECOMMENDATIONS FROM THE RODGER C. HAGGITT GASTROINTESTINAL

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Imaging Evaluation of Polyps. CT Colonography: Sessile Adenoma. Polyps, DALMs & Megacolon Objectives

The Digestive System Laboratory

Chromoendoscopy and Endomicroscopy for detecting colonic dysplasia

ATLAS OF HEAD AND NECK PATHOLOGY METAPLASIA

Small Bowel Cases. Introduction. Introduction, Continued 12/7/2011. Lesions Found on endoscopic biopsies Just Like Signing Out

Gastrooesophageal reflux disease. Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

polyps of the colon and rectum

Present Day Management of Barrett s Esophagus

1. Esophageal diverticulum located above the upper esophageal sphincter is called

B Barrett neoplasia, early, endoscopic mucosal resection of, in Europe, 297

Muco-epidermoid tumours of the anal canal

11/1/2017. Tetyana Mettler, MD Department of Laboratory Medicine and Pathology University of Minnesota. Cerilli & Greenson

In 1998, the American College of Gastroenterology issued ALIMENTARY TRACT

PATHOLOGY OF NON NEOPLASTIC LESIONS OF THE UPPER GASTROINTESTINAL TRACT.

Vital staining and Barrett s esophagus

Gastroesophageal junction Paneth cell carcinoma with extensive cystic and secretory features case report and literature review

HISTOLOGY. GIT Block 432 Histology Team. Lecture 1: Alimentary Canal (1) (Esophagus & Stomach) Done by: Ethar Alqarni Reviewed by: Ibrahim Alfuraih

HDF Case Whipple s disease

Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens

HDF Case CRYPTOSPORIDIOSE

Alimentary Canal (I)

Protocol for the Examination of Specimens From Patients With Carcinoma of the Esophagus

What is your diagnosis? a. Lymphocytic colitis. b. Collagenous colitis. c. Common variable immunodeficiency (CVID) associated colitis

The increasing incidence of esophageal adenocarcinoma

Corporate Medical Policy

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

The present staging system for esophageal carcinoma

Gastrointestinal Disorders. Disorders of the Esophagus 3/7/2013. Congenital Abnormalities. Achalasia. Not an easy repair. Types

Definition of GERD American College of Gastroenterology

A916: rectum: adenocarcinoma

Barrett s s Dysplasia

In-situ and invasive carcinoma of the colon in patients with ulcerative colitis

ORIGINAL ARTICLE. Adenocarcinoma of the Esophagus With and Without Barrett Mucosa

Management of Barrett s Esophagus. Case Presentation

Esophageal cancer: Biology, natural history, staging and therapeutic options

Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

The normal esophagus is lined with squamous epithelium.

Learning Objectives:

Ablation for Barrett s Esophagus: Burn or Freeze

Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett s Esophagus

Current challenges in Barrett s esophagus

MBP AP 3 Core Curriculum

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS GASTROINTESTINAL (GI) PATHOLOGY LAB #1. January 06, 2012

A Multidisciplinary Approach to Esophageal Dysphagia: Role of the SLP. Darlene Graner, M.A., CCC-SLP, BRS-S Sharon Burton, M.D.

Transcription:

THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org

The American Board of Pathology (ABP) approves educational providers to offer accredited AMA PRA Category 1 CME activities as SAM eligible for meeting MOC Part II requirements. To become an ABP-approved SAMs provider, complete and submit the SAM Provider Agreement located on our website. After being approved by the ABP to offer SAM eligible CME activities, follow the guidelines included here to develop your self-assessment modules and construct your annual SAMs report. SAMs may be delivered in a variety of methods. online module or webinar live course or lecture annual, monthly, or weekly symposium journal article US Mail (typically slide review programs) SAMs must incorporate at least one of the following ACGME core competencies in their content. Patient Care (PC) Medical Knowledge (MK) Practice-Based Learning and Improvement (PB) Interpersonal and Communication Skills (IC) Professionalism (PF) Systems-Based Practice (SB) According to ACCME criteria, self-assessment modules must describe and demonstrate a comprehensive process of establishing a gap and underlying the educational need. All activities offered as SAM eligible CME must be clearly denoted as such in course descriptions and on completion certificates.

A post-test is required for SAM eligibility. A pre-test is recommended to identify or demonstrate gaps in learned knowledge. Attendees must achieve a pass rate on the post-test set by the provider (typically 75 to 80 percent) to earn SAM credits for the course. Attendees may be allowed to take the post-test more than once in order to achieve the minimum performance level. Attendees must be provided immediate feedback including a brief explanation and reference(s) for the correct answer. Post-tests and feedback may be offered online to attendees of live courses and annual symposiums. Three to five questions per half hour of instructional time is recommended. Guidelines for developing test questions: The test question should be an important concept that is medically (clinically) relevant. In addition, it should correlate to a particular learning objective, and from the pathologists viewpoint be fair. Images or slides may be incorporated into the test questions. Where possible, questions should be written as a short clinical vignette (stem). The stem should be answerable virtually without looking at the choices. The focus should be on information of value and problem-solving rather than common knowledge. Questions should be stated as a positive rather than as a negative. Do not use stems with except or none of the following. Avoid absolutes such as always and never. Answer choices should be in alphabetical order and approximately the same length and type (there is a tendency to give more information about the correct response and therefore make it longer). Questions should generally have a single best response (definitive answer) and four or five distractors (incorrect answers). Do not use K type questions (A=1, 2, and 3 correct).

Sample test questions: 1) Which of the following statements regarding Barrett s esophagus is true? A. A biopsy of the gastroesophageal junction with goblet cells is diagnostic of Barrett s esophagus. B. Alcian blue staining is required to confirm the identification of goblet cells. C. At least 2 cm of columnar-lined esophagus is required to make a diagnosis of Barrett s esophagus. D. Goblet cells must be identified in a biopsy from an area of columnar-lined esophagus. E. The identification of cardiac and fundic-type mucosa is sufficient to render a diagnosis of Barrett s esophagus. Correct answer: D Explanation: Barrett s esophagus can be diagnosed if an endoscopic abnormality is seen (columnar-lined esophagus) and goblet cells are identified in a biopsy taken from the area of endoscopic abnormality. Although cardiac and fundic-type mucosa is frequently seen in patients with Barrett s esophagus, it is not sufficient to render this diagnosis, as goblet cells are necessary. Although an Alcian blue stain will confirm the presence of acid mucin in goblet cells, this stain is not required for their identification. Intestinal metaplasia of the gastroesophageal junction seems to be a multifactorial condition which is not necessarily indicative of Barrett s esophagus. Reference: Hirota WK, Loughney TM, Lazis DJ, et al. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116:277. 2) Which of the following statements is true regarding the image from a 72-year-old male with a long-standing history of Barrett s esophagus? A. The absence of goblet cells in the surrounding mucosa suggests a gastric tumor secondarily involving the distal esophagus. B. This biopsy reveals an intraepithelial proliferation. C. This lesion can metastasize to lymph nodes. D. This patient is best treated by periodic endoscopy with numerous biopsies. E. Up to 80% of patients with Barrett s esophagus present with this finding at initial diagnosis. Correct answer: C

Explanation: This biopsy shows invasion of individual cells into the lamina propria, consistent with intramucosal adenocarcinoma. Although some patients with Barrett s esophagus do present with this finding, most patients have no evidence of dysplasia or adenocarcinoma in their initial diagnostic biopsy. Because there are lymphatic channels in the esophageal mucosa, this lesion can metastasize to lymph nodes. Given this fact, definitive therapy (either endoscopic mucosal resection or esophagectomy with or without ablation therapy) is required. Although goblet cells may not be found in the surrounding mucosa, adenocarcinomas can overrun the surrounding Barrett s mucosa such that goblet cells may not be found. Reference: Sabik JF, Rice TW, Goldblum JR, et al. Superficial esophageal carcinoma. Ann Thorac Surg 1995: 60:896. 3) Which of the following statements regarding normal colon is true? A. Eosinophils are not a normal component of the lamina propria of the normal colon. B. Goblet cell density is greatest in the cecum. C. Lamina propria cellularity decreases from the right colon to the rectum. D. Normal colon shows fewer than 5 lymphocytes/100 epithelial cells throughout the entire colon. E. Paneth cells are a normal component of the crypt epithelium in the left colon. Correct answer: C Explanation: The right colon has histologic differences from the left colon. In particular, there is a progressive decrease in the lamina propria cellularity as well as a progressive decrease in the number of surface epithelial lymphocytes as one moves from the cecum to the rectum. There can be up to 10 lymphocytes per 100 epithelial cells or even more present in the right colon. The rectum also has far more goblet cells than other parts of the colon. Paneth cells can be present in the right colon but are not a normal component of the colon distal to the right colon. Reference: Lazenby AJ. Collagenous and lymphocytic colitis. Semin Diagn Pathol 2005; 22:295. 4) Ulcerative colitis is characterized by which of the following? A. Absence of rectal involvement at presentation in adults. B. Features of chronicity, including basal plasmacytosis and glandular distortion. C. Frequent involvement of the proximal small bowel. D. Patchy disease in the untreated setting. E. Pyloric gland metaplasia is a consistent finding. Correct answer: B Explanation: The right colon has histologic differences from the left colon. In particular, there is a progressive decrease in the lamina propria cellularity as well as a progressive decrease in the number of surface epithelial lymphocytes as one moves from the cecum to the rectum. There can be up to 10 lymphocytes per 100 epithelial cells or even more present in the right colon. The rectum also has far more goblet cells than other parts of the colon. Paneth cells can be present in the right colon but are not a normal component of the colon distal to the right colon.

Reference: Surawicz CM, Haggitt RC, Husseman M, et al. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 1994; 107:755. All approved SAM providers will be required to submit an annual SAMs report to ABP. This report will be requested by ABP via email at the onset of each year and must be received by April 1 st. Failure to submit a SAMs report will result in suspension of SAM provider approval. SAMs report submission via email to ABP-MOC@abpath.org in Excel format is preferred. Example of annual SAMs report: ABP-APPROVED SAM PROVIDER NAME NAME OF SAM ACTIVITY METHOD OF DELIVERY ACGME COMPETENCIES # CREDITS Molecular Biomarkers in Breast Cancer: How Do We Best Get to the Truth? annual symposium MK 2.50 2015 CPIP-D Case 04 - Special Considerations for Neonates online module MK, PB, SB 1.25 Multidisciplinary Hematopathology Conference weekly symposium PC, MK, PB, IC, PF, SB 1.00 Practical and Effective Diagnostic Hematopathology live course PC, MK, PB, IC, PF, SB 5.00 Latest Developments in Forensic Pathology and Forensic Toxicology journal MK, PB 13.00 2015-2016 Glass Slides Subscription A US mail PC, MK, PB 16.00 ACGME competencies: PC MK PB IC PF SB PATIENT CARE MEDICAL KNOWLEDGE PRACTICE-BASED LEARNING AND INPROVEMENT INTERPERSONAL AND COMMUNICATION SKILLS PROFESSIONALISM SYSTEMS-BASED PRACTICE